Answers are grounded in this paper and cite their sources.
Assessment demonstrates significant correlation in NT-proBNP assays for heart failure, suggesting they may be interchangeably used at guideline cutpoints.
Three NT-proBNP assay platforms demonstrated high correlation, minimal bias, and high clinical concordance. The results support the clinical interchangeability of these assays at commonly used and guideline-endorsed cutpoints.
No takes yet. Share an insight, caveat, or question.
Mensah et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: